The aim of this study was to compare serum NtproBNP levels in NSTE-ACS patients and controls and to assess the relation between serum N-terminal pro brain natriuretic peptide (Nt- proBNP) and the severity of coronary artery disease (CAD) in patients with non-ST elevation acute coronary syndrome NSTE-ACS [unstable angina and NSTEMI].
(2021). Nt-Probnp in Assessment of Severity of Coronary Artery Disease in Patients with Non-ST Elevation Acute Coronary Syndrome. Cardiovascular Research Prove Journal, 5(1), -. doi: 10.21608/cvrepj.2021.351600
MLA
. "Nt-Probnp in Assessment of Severity of Coronary Artery Disease in Patients with Non-ST Elevation Acute Coronary Syndrome", Cardiovascular Research Prove Journal, 5, 1, 2021, -. doi: 10.21608/cvrepj.2021.351600
HARVARD
(2021). 'Nt-Probnp in Assessment of Severity of Coronary Artery Disease in Patients with Non-ST Elevation Acute Coronary Syndrome', Cardiovascular Research Prove Journal, 5(1), pp. -. doi: 10.21608/cvrepj.2021.351600
VANCOUVER
Nt-Probnp in Assessment of Severity of Coronary Artery Disease in Patients with Non-ST Elevation Acute Coronary Syndrome. Cardiovascular Research Prove Journal, 2021; 5(1): -. doi: 10.21608/cvrepj.2021.351600
)
View on SCiNiTO